Wealth Enhancement Advisory Services LLC Has $8.61 Million Stock Position in SPDR S&P Biotech ETF $XBI

Wealth Enhancement Advisory Services LLC cut its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 14.0% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 100,986 shares of the exchange traded fund’s stock after selling 16,442 shares during the quarter. Wealth Enhancement Advisory Services LLC owned 0.17% of SPDR S&P Biotech ETF worth $8,608,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. Bourgeon Capital Management LLC lifted its stake in SPDR S&P Biotech ETF by 6.1% in the first quarter. Bourgeon Capital Management LLC now owns 2,822 shares of the exchange traded fund’s stock valued at $229,000 after buying an additional 163 shares during the period. First Heartland Consultants Inc. lifted its stake in SPDR S&P Biotech ETF by 2.7% in the first quarter. First Heartland Consultants Inc. now owns 6,344 shares of the exchange traded fund’s stock valued at $514,000 after buying an additional 168 shares during the period. Calton & Associates Inc. lifted its stake in SPDR S&P Biotech ETF by 3.2% in the first quarter. Calton & Associates Inc. now owns 5,662 shares of the exchange traded fund’s stock valued at $459,000 after buying an additional 175 shares during the period. Arlington Financial Advisors LLC lifted its stake in SPDR S&P Biotech ETF by 0.8% in the first quarter. Arlington Financial Advisors LLC now owns 22,685 shares of the exchange traded fund’s stock valued at $1,840,000 after buying an additional 181 shares during the period. Finally, Institute for Wealth Management LLC. lifted its stake in SPDR S&P Biotech ETF by 2.0% in the first quarter. Institute for Wealth Management LLC. now owns 9,676 shares of the exchange traded fund’s stock valued at $785,000 after buying an additional 186 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $97.30 on Tuesday. SPDR S&P Biotech ETF has a 52-week low of $66.66 and a 52-week high of $105.47. The business’s 50 day moving average price is $89.88 and its two-hundred day moving average price is $84.34. The firm has a market cap of $5.30 billion, a PE ratio of 11.47 and a beta of 0.97.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.